Iterum Therapeutics plc (ITRM)
NASDAQ: ITRM · Real-Time Price · USD
0.0356
-0.1404 (-79.77%)
At close: Mar 27, 2026, 4:00 PM EDT
0.0369
+0.0013 (3.65%)
After-hours: Mar 27, 2026, 7:59 PM EDT
Iterum Therapeutics Employees
Iterum Therapeutics had 9 employees as of December 31, 2024. The number of employees decreased by 5 or -35.71% compared to the previous year.
Employees
9
Change (1Y)
-5
Growth (1Y)
-35.71%
Revenue / Employee
$43,333
Profits / Employee
-$2,995,667
Market Cap
1.88M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 9 | -5 | -35.71% |
| Dec 31, 2023 | 14 | 0 | - |
| Dec 31, 2022 | 14 | 1 | 7.69% |
| Dec 31, 2021 | 13 | 6 | 85.71% |
| Dec 31, 2020 | 7 | -37 | -84.09% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Scinai Immunotherapeutics | 31 |
| Calidi Biotherapeutics | 28 |
| Ensysce Biosciences | 8 |
| Enveric Biosciences | 6 |
| Galmed Pharmaceuticals | 6 |
| Adial Pharmaceuticals | 5 |
| Oragenics | 5 |
| CNS Pharmaceuticals | 5 |
ITRM News
- 1 day ago - Iterum files wind-up petition due to limited cash, inability to raise equity - Reuters
- 1 day ago - Iterum Therapeutics Announces Filing of Winding Up Petition - GlobeNewsWire
- 6 weeks ago - Iterum Therapeutics Provides Business Update - GlobeNewsWire
- 4 months ago - Iterum Therapeutics Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 5 months ago - Iterum Therapeutics to Report Third Quarter 2025 Financial Results on Friday, November 14, 2025 - GlobeNewsWire
- 5 months ago - Iterum Therapeutics to Present Data at IDWeek 2025 - GlobeNewsWire
- 7 months ago - Iterum Therapeutics launches ORLYNVAH™, the first and only oral penem antibiotic in the U.S. - GlobeNewsWire
- 8 months ago - Iterum Therapeutics Reports Second Quarter 2025 Financial Results - GlobeNewsWire